Name: UMIN ID:
Unique ID issued by UMIN | UMIN000053483 |
---|---|
Receipt number | R000061044 |
Scientific Title | Cost-effectiveness study of atezolizumab vs. durvalumab : real-world data on first-line chemotherapy combined with immune-checkpoint inhibitors for extensive disease small-cell lung cancer |
Date of disclosure of the study information | 2024/01/30 |
Last modified on | 2024/01/30 18:47:26 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2024/01/30 18:45:24 | ||
2 | Update | 2024/01/30 18:47:26 | Recruitment status Date of IRB |